Cyclophosphamide
Cyclophosphamide is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Cyclophosphamide; Generic name: CYCLOPHOSPHAMIDE; Manufacturer: Sandoz Inc..
| Brand name | Cyclophosphamide |
|---|---|
| Generic name | CYCLOPHOSPHAMIDE |
| Manufacturer | Sandoz Inc. |
| Used for | 1 INDICATIONS AND USAGE Cyclophosphamide is an alkylating drug indicated for treatment of: Malignant Diseases: malignant lymphomas: Hodgkin's disease, lymphocytic lymphoma, mixed-cell type lymphoma, histiocytic lymphoma, Burkitt's lymphoma; multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of ovary, retinoblastoma, breast carcinoma ( 1.1 ) Minimal Change Nephrotic Syndrome in Pediatric Patients: biopsy proven minimal change nephrotic syndrome patients who failed to adequately respond to or are unable to tolerate adrenocorticosteroid therapy ( 1.2 ) Limitations of Use: The safety and effectiveness for the treatment of nephrotic syndrome in adults or other renal dis |
| Dosage | 2 DOSAGE AND ADMINISTRATION During or immediately after the administration, adequate amounts of fluid should be ingested or infused to force diuresis in order to reduce the risk of urinary tract toxicity. Therefore, cyclophosphamide should be administered in the morning. Malignant Diseases: Adult and Pediatric Patients ( 2.1 ) Intravenous: Initial course for patients with no hematologic deficiency: 40 mg per kg to 50 mg per kg in divided doses over 2 to 5 days. Other regimens include 10 mg per k |
| Active ingredient(s) | CYCLOPHOSPHAMIDE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e9e22fa-178a-42fc-9f82-c303db3b245a |